Carlos Cruchaga, a member of BrightFocus Foundations Alzheimers Disease Research Scientific Review Committee, and grantee Laura Ibaez, PhD, presented data on the circRNA biomarker model that could more accurately identify and diagnose Alzheimers in the blood
At his primary care providers direction, he then increased to 5 mg weekly for 12 weeks
The value has a small fluctuation range under physiological conditions
Readers should consult a qualified clinician before starting, changing, or stopping any prescription medication or weight-loss program
Study 8 (TAUSSIG, NCT01624142) was a multicenter, open-label 5-year extension study with REPATHA in 106 patients with HoFH, who were treated with REPATHA as an adjunct to other lipid-lowering therapies